Sanz F, Soledad Cuétara M, del Palacio A, Campbell C K, Johnson L, Urruzunu P, Pía Roiz M
Public Health Laboratory, Micological Reference Laboratory, Londres, Reino Unido.
Enferm Infecc Microbiol Clin. 1993 Nov;11(9):490-3.
F. solani fungemia is unusual. Patients at risk are immunosuppressed, have underlying malignancy or severe debilitating diseases.
We report two cases of F. solani fungemia in two non neutropenic patients who had been treated with wide-spectrum antibiotics an/or systemic corticosteroids, parenteral nutrition and intravenous lines. Bactec NR-860 (Becton-Dickinson) system was used, and growth was detected in aerobic conditions (between 3-7 days of incubation).
Removal of the catheters with or without i.v. amphotericin B were used successfully.
The spectrum of Fusarium sp. fungemia is discussed. Current available antifungal therapy is also reviewed.
